Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chizhou Fangda Science and Technology is a chemical manufacturing enterprise based in Chizhou, Anhui Province, China. Established in 2005, the company specializes in the research, development, and large-scale production of fine chemicals and pharmaceutical intermediates, with a particular focus on pyridine derivatives. Its flagship products include 2-chloro-5-chloromethylpyridine (CCMP) and 2-chloro-5-methylpyridine, which are vital components in the synthesis of neonicotinoid insecticides and various pharmaceutical active ingredients. The company serves a global clientele across the agrochemical and life sciences industries, operating from a significant manufacturing base in the Chizhou High-tech Industrial Development Zone. Chizhou Fangda is recognized for its industrial-scale synthesis capabilities and adherence to rigorous quality management standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chizhou Fangda Science and Technology.